Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
Vimentin Antibody, Novus Biologicals™

Rabbit Polyclonal Antibody has been used in 6 publications
Supplier: Novus Biologicals NBP131327
Description
Vimentin Polyclonal specifically detects Vimentin in Human, Mouse, Rat, Equine samples. It is validated for Western Blot, ELISA, Immunohistochemistry, Immunocytochemistry/Immunofluorescence, Immunoprecipitation, Immunohistochemistry-Paraffin, Immunohistochemistry-Frozen, Sandwich ELISA, Knockdown Validated.Specifications
Vimentin | |
Polyclonal | |
Unconjugated | |
PBS, 1% BSA, 20% Glycerol (pH7) with 0.025% Proclin 300 | |
VIM | |
Recombinant protein encompassing a sequence within the center region of human Vimentin. The exact sequence is proprietary. | |
Affinity Purified | |
RUO | |
Primary | |
Expected to cross react based on sequence identity: Chimpanzee 100%. | |
Aliquot and store at -20C or -80C. Avoid freeze-thaw cycles. |
Western Blot, ELISA, Immunohistochemistry, Immunocytochemistry, Immunofluorescence, Immunoprecipitation, Immunohistochemistry (Paraffin), Immunohistochemistry (Frozen) | |
1.0mg/mL | |
Western Blot 1:5000-1:50000, ELISA Assay dependent., Immunohistochemistry Assay dependent., Immunocytochemistry/Immunofluorescence 1:100-1:1000, Immunoprecipitation 1:100-1:500, Immunohistochemistry-Paraffin Assay dependent., Immunohistochemistry-Frozen Assay dependent., Sandwich ELISA Assay dependent., Knockdown Validated | |
FLJ36605, vimentin | |
Rabbit | |
54 kDa | |
0.1 mL | |
Cancer, Cellular Markers, Cytoskeleton Markers, Growth and Development, Hypoxia, Neuronal Cell Markers, Neuronal Stem Cell Markers, Neuroscience, Signal Transduction, Stem Cell Markers, Stem Cells | |
7431 | |
Human, Mouse, Rat, Equine | |
IgG |
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
For Research Use Only
Spot an opportunity for improvement?Share a Content Correction